220 related articles for article (PubMed ID: 24436475)
1. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.
Thomsen M; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
Clin Chem; 2014 May; 60(5):737-46. PubMed ID: 24436475
[TBL] [Abstract][Full Text] [Related]
2. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
Varbo A; Freiberg JJ; Nordestgaard BG
Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
[TBL] [Abstract][Full Text] [Related]
3. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
4. Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals.
Varbo A; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):464-472. PubMed ID: 29097364
[TBL] [Abstract][Full Text] [Related]
5. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
[TBL] [Abstract][Full Text] [Related]
6. Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
Kaltoft M; Langsted A; Nordestgaard BG
Eur Heart J; 2020 Jun; 41(24):2288-2299. PubMed ID: 32267934
[TBL] [Abstract][Full Text] [Related]
7. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
8. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
Langsted A; Nordestgaard BG
Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
[TBL] [Abstract][Full Text] [Related]
9. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
10. Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population: Mendelian randomization study.
Ooi EM; Afzal S; Nordestgaard BG
Circ Cardiovasc Genet; 2014 Oct; 7(5):650-8. PubMed ID: 25065375
[TBL] [Abstract][Full Text] [Related]
11. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
[TBL] [Abstract][Full Text] [Related]
12. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
13. Nonfasting triglycerides and risk of ischemic stroke in the general population.
Freiberg JJ; Tybjaerg-Hansen A; Jensen JS; Nordestgaard BG
JAMA; 2008 Nov; 300(18):2142-52. PubMed ID: 19001625
[TBL] [Abstract][Full Text] [Related]
14. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.
Pedersen SB; Langsted A; Nordestgaard BG
JAMA Intern Med; 2016 Dec; 176(12):1834-1842. PubMed ID: 27820614
[TBL] [Abstract][Full Text] [Related]
15. Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease.
Jepsen AM; Langsted A; Varbo A; Bang LE; Kamstrup PR; Nordestgaard BG
Clin Chem; 2016 Apr; 62(4):593-604. PubMed ID: 26888894
[TBL] [Abstract][Full Text] [Related]
16. Genetically low triglycerides and mortality: further support for "the earlier the better"?
Martin SS; Blaha MJ
Clin Chem; 2014 May; 60(5):705-7. PubMed ID: 24607483
[No Abstract] [Full Text] [Related]
17. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
18. Contribution of remnant cholesterol to cardiovascular risk.
Langsted A; Madsen CM; Nordestgaard BG
J Intern Med; 2020 Jul; 288(1):116-127. PubMed ID: 32181933
[TBL] [Abstract][Full Text] [Related]
19. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Eur Heart J; 2023 Apr; 44(16):1432-1445. PubMed ID: 36631967
[TBL] [Abstract][Full Text] [Related]
20. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
